Muthusamy Shanmugam - 26 Feb 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
HEAD OF R&D, COO-NOVITIUM OPS, Director
Signature
/s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
26 Feb 2026
Net transactions value
+$857,599
Form type
4
Filing time
02 Mar 2026, 17:59:46 UTC
Previous filing
13 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS, Director C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE /s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook 02 Mar 2026 0001870913

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Award $857,599 +11,116 +12% $77.15 101,056 26 Feb 2026 Direct F1
holding ANIP Common Stock 431,920 26 Feb 2026 Held by Esjay LLC F2
holding ANIP Common Stock 5,000 26 Feb 2026 Held by SS Pharma LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026.
F2 The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
F3 The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.